Foxconn was among the investors in a $35m second tranche of a round also backed by Aviva Ventures which now stands at $50m.

Legend Capital returned to back a $43.7m round for endoscope producer Aohua, which will use the proceeds to expand internationally.

Roche Venture Fund and Chiesi Ventures returned for a $25m round that lifted the orphan disease therapy developer's total funding to more than $51m.

Merck & Co and Takeda are in line for exits when drug developer NGM Biopharmaceuticals lists on the Nasdaq Global Select Market.

ASR Insurances and KLP are among the limited partners in Forbion IV, which will invest in biopharmaceutical companies across Europe and North America.

GM&C Life Sciences Fund has stumped up an unspecified sum for Manchester digital health app spinout Clin-e-cal, which creates apps focused on respiratory conditions.

Hong Ma, professor of biology, has been appointed associate dean for research and innovation at Penn State’s Eberly College of Science.

Medical diagnostics developer Drawbridge Health has secured capital from Kyoto University Innovation Capital thanks to a meeting at the GUV: Fusion conference.

Laboratory services supplier Bellen Chemistry has followed a Legend Capital-backed round last year by raising a nine-figure renminbi sum.

Existing investor Takeda Ventures was among the participants in a round that valued the cancer therapy developer at approximately $100m.